Which peptides can be prescribed through telehealth in 2026?
Through HOO, a licensed provider can prescribe sermorelin, PT-141, glutathione and topical GHK-Cu, prepared by a licensed US pharmacy for an individual patient.
Peptides in 2026
Through HOO, a licensed provider can prescribe four peptides after an online visit: sermorelin, PT-141, glutathione and topical GHK-Cu, prepared by a licensed US pharmacy. Research peptides such as BPC-157, TB-500, KPV, MOTS-c, Semax, Epitalon, CJC-1295 and ipamorelin are not offered.
$0 to start. $0 a month through December 31, 2026, then a flat $250 a month. No minimum order, no inventory, no commission split. You set your own prices.
Updated October 22, 2026
Offered
| Peptide | Form | What it is |
|---|---|---|
| Sermorelin | Injection | A growth hormone-releasing hormone analog, prescribed by a licensed provider |
| PT-141 | Injection or nasal spray | Used in sexual wellness programs, prescribed by a licensed provider |
| Glutathione | Injection or nasal spray | A tripeptide offered in wellness programs |
| GHK-Cu | 2% or 4% topical cream | A copper peptide used in prescription skin programs. Topical only |
Not offered
| Peptide | Status on FDA's bulk substances page (April 22, 2026) |
|---|---|
| BPC-157 | Nominated for compounding and withdrawn |
| TB-500 (thymosin beta-4 fragment) | Nominated for compounding and withdrawn |
| KPV, MOTS-c, Semax, Epitalon | Nominated for compounding and withdrawn |
| CJC-1295 | Nominated for compounding and withdrawn |
| Ipamorelin, GHRP-2, GHRP-6 | Category 2: may present significant safety risks |
| GHK-Cu, injectable | Nominated for compounding and withdrawn (topical cream is offered) |
Source: FDA, Certain Bulk Drug Substances for Use in Compounding that May Present Significant Safety Risks. Rules change, so we review this page regularly. This is general information, not legal or medical advice.
FAQ
Through HOO, a licensed provider can prescribe sermorelin, PT-141, glutathione and topical GHK-Cu, prepared by a licensed US pharmacy for an individual patient.
HOO does not offer BPC-157.
BPC-157 appears on FDA's page of bulk drug substances among those nominated for compounding and withdrawn (FDA, updated April 22, 2026).
They are not for human use, and HOO does not offer them.
HOO offers GHK-Cu as a topical cream only.
Injectable GHK-Cu appears on FDA's list of substances nominated for compounding and withdrawn.
For businesses
Apply in about two minutes, or pick a time for a 15-minute partner call on Google Meet. $0 to start.
For individuals
Go straight to the online intake, where a licensed provider reviews your information.